Morning Overview on MSN
Scientists may have created a universal cancer vaccine, and it’s huge
Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...
Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
The Federal Government has trained scientists drawn from key research institutions across the country on mRNA technology ...
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Morning Overview on MSN
MIT team finds a way to reboot the immune system
Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns ...
Meanwhile, GC Biopharma was recently selected as a recipient of Phase 1 clinical research support under the Korea Disease ...
The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...
University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback